Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
Abstract In-stent restenosis (ISR) represents a major complication after stenting of intracranial artery stenosis (ICAS). Biomarkers derived from routine blood sampling including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and mean platelet volu...
Guardado en:
Autores principales: | Melanie Haidegger, Markus Kneihsl, Kurt Niederkorn, Hannes Deutschmann, Harald Mangge, Christian Vetta, Michael Augustin, Gerit Wünsch, Simon Fandler-Höfler, Susanna Horner, Christian Enzinger, Thomas Gattringer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96c7f491c19841828958689edfffea87 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety of endovascular therapy for symptomatic intracranial artery stenosis: a national prospective registry
por: Yongli Li, et al. -
Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis
por: Gerrit M. Grosse, et al.
Publicado: (2021) -
Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
por: Kun Zhang, et al.
Publicado: (2021) -
Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis
por: Norio Kanamori, et al.
Publicado: (2018) -
Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis
por: Luo Y, et al.
Publicado: (2021)